Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T77664 | ||||
Target Name | Interferon gamma | ||||
Synonyms | IFN-gamma; Immune interferon; IFNG | ||||
Target Type | Clinical Trial | ||||
Gene Name | IFNG | ||||
Biochemical Class | Cytokine: interferon | ||||
UniProt ID | IFNG_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Multiple sclerosis | ||||
Example drug | Fumaric acid | Phase 3 | [536837], [1572592] | ||
Tissue | Spinal cord | ||||
Level of differential expression between the patients in the disease section of the tissue and the patients in the normal section of the tissue adjacent to the disease section | Fold-change: 0.04 Z-score: 0.19 P-value: 5.36E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
|
|||||
Disease | Prostate cancer | ||||
Example drug | VPM-4-001 | Preclinical | [548240], [1572592] | ||
Tissue | Prostate | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.02 Z-score: 0.04 P-value: 3.25E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Rheumatoid arthritis | ||||
Example drug | Fontolizumab | Discontinued in Phase 2 | [536651], [1572592] | ||
Tissue | Synovial tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -2.90E-03 Z-score: -0.01 P-value: 3.56E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
Reference | |||||
Ref 548240 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023655) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.